Author Of 8 Presentations

GREETINGS

Room
Mozart Hall 2
Date
18.06.2019
Session Time
18:15 - 19:15
Duration
5 Minutes

Presentation files

Hide

WELCOME & INTRODUCTION

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
4 Minutes

CONGENITAL VS. ACQUIRED PROTEIN C DEFICIENCY

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
10 Minutes

CONCLUSION

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
5 Minutes

GENDER DIFFERENCES IN INFANT MORTALITY IN UK PAEDIATRIC INTENSIVE CARE UNITS LONG TERM OUTCOME

Abstract

Background

Most children who die in UK Paediatric Intensive Care Units (PICUs) are infants. Male infants have higher mortality compared to female infants globally. Specific reasons that drive the UK gender disparity have not been studied.

Objectives

To study gender differences in UK PICU mortality and investigate factors that may explain these differences

Methods

We extracted data from UK PICUs from 01/2005 to 12/2015 and included all infants aged 0-12 months admitted to PICU. To investigate potential aetiological causes for differences in mortality, we used a parametric cause-specific hazard ratio (CSHR) with restricted cubic splines, time varying coefficients, and cluster robust standard errors. Variables used for risk adjustment were a recalibrated version of PIM2, age at admission, elective or emergency admission, infection, year and month of admission, inotropic and renal support.

Results

We analysed records of 71,242 infants from 35 PICUs. More female than male infants died (1809/41723, 4.3% versus 1411/29519, 4.8% for males/females respectively). The adjusted CSHR for males versus females was 0.88 (95% CI 0.82 to 0.95, p=0.001). Higher PIM2 score, infection, inotropic and renal support were all strongly associated with an increased CSHR for mortality. Older age and later years were strongly associated with deccreased mortality. None of the factors investigated altered the CSHR. The CSHR of gender was at its lowest during the first three days of admission, suggesting that whatever drives higher female mortality occurs early after admission.

Conclusion

UK female infants have higher PICU mortality than male infants. The reason behind this finding is unclear and needs further investigation.

Hide

FROM CLINICAL TRIALS TO PRACTICE - LOST IN TRANSLATION?

Room
Papageno Hall
Date
20.06.2019
Session Time
15:40 - 17:10
Duration
20 Minutes

Presentation files

Hide

NEW VASO-ACTIVE DRUGS

Room
Papageno Hall
Date
21.06.2019
Session Time
11:10 - 11:50
Session Name
Duration
20 Minutes

Presentation files

Hide

Closing Lecture

Room
Mozart Hall 1
Date
21.06.2019
Session Time
12:00 - 13:30
Session Name
Duration
30 Minutes

Video on Demand

[session]
[presentation]
[presenter]
Hide

Presenter of 7 Presentations

GREETINGS

Room
Mozart Hall 2
Date
18.06.2019
Session Time
18:15 - 19:15
Duration
5 Minutes

Presentation files

Hide

WELCOME & INTRODUCTION

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
4 Minutes

CONGENITAL VS. ACQUIRED PROTEIN C DEFICIENCY

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
10 Minutes

CONCLUSION

Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
Duration
5 Minutes

FROM CLINICAL TRIALS TO PRACTICE - LOST IN TRANSLATION?

Room
Papageno Hall
Date
20.06.2019
Session Time
15:40 - 17:10
Duration
20 Minutes

Presentation files

Hide

NEW VASO-ACTIVE DRUGS

Room
Papageno Hall
Date
21.06.2019
Session Time
11:10 - 11:50
Session Name
Duration
20 Minutes

Presentation files

Hide

Closing Lecture

Room
Mozart Hall 1
Date
21.06.2019
Session Time
12:00 - 13:30
Session Name
Duration
30 Minutes

Video on Demand

[session]
[presentation]
[presenter]
Hide

Moderator of 7 Sessions

PLENARY SESSION
Session Description
17.15-18.15
Room
Mozart Hall 2
Date
18.06.2019
Session Time
18:15 - 19:15
LONG SCIENTIFIC SESSION
Room
Doppler Hall
Date
19.06.2019
Session Time
09:10 - 10:40
LONG SCIENTIFIC SESSION
Room
Doppler Hall
Date
21.06.2019
Session Time
09:10 - 10:40
SPONSORED SESSION
Room
Mozart Hall 2
Date
19.06.2019
Session Time
12:30 - 13:30
PRESIDENT'S SESSION
Room
Mozart Hall 1
Date
21.06.2019
Session Time
12:00 - 13:30

Session Webcast

POSTER WALK
Room
Poster Area 3
Date
20.06.2019
Session Time
12:20 - 13:40
SPONSORED SESSION
Session Description
CEPROTIN® TREATMENT IN THE MANAGEMENT OF SCPCD
Room
Exhibition Area
Date
20.06.2019
Session Time
10:40 - 11:10